Biocept (BIOC)

Sorry, no known transcripts

Recent filings

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Jan. 11, 2017

Notice of Delisting or - Dec. 2, 2016

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Nov. 10, 2016

Biocept Reports 2016 Third Quarter Financial Results - Nov. 9, 2016

Termination of a Material Definitive - Nov. 4, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Oct. 28, 2016

Major owner of Biocept just declared owning 1,681,000 shares of Biocept - Oct. 24, 2016

Daniel V. Tierney just provided an update on share ownership of Biocept - Oct. 24, 2016

Biocept's CEO & President just picked up 36,363 shares - Oct. 21, 2016

Biocept director just picked up 4,545 shares - Oct. 21, 2016

Biocept director just picked up 20,000 shares - Oct. 21, 2016

CFO of Biocept just picked up 36,363 shares - Oct. 21, 2016

Biocept's Sr VP & Sr Med Director just picked up 10,000 shares - Oct. 21, 2016

Biocept director just picked up 50,000 shares - Oct. 21, 2016

Biocept's SR VP of R&D and CSO just picked up 45,000 shares - Oct. 21, 2016

Biocept director just picked up 13,636 shares - Oct. 21, 2016

Major owner of Biocept just picked up 227,272 shares - Oct. 21, 2016

Biocept director just picked up 227,272 shares - Oct. 21, 2016

Biocept director just picked up 90,909 shares - Oct. 21, 2016

Bin Li just provided an update on activist position in Biocept - Oct. 20, 2016

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Oct. 17, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Oct. 14, 2016

Post-effective amendment adding exhibits to registration statement [Rule 462(d)] - Oct. 14, 2016

Biocept Just Received a Notice of Effectiveness - Oct. 13, 2016

General form for registration of securities under the Securities Act of 1933 - Oct. 6, 2016

General form for registration of securities under the Securities Act of 1933 - Sept. 29, 2016

Biocept: Risks Relating To Our Financial Condition And Capital Requirements - Sept. 29, 2016

Other definitive proxy statements - Aug. 31, 2016

General form for registration of securities under the Securities Act of 1933 - Aug. 12, 2016

Other preliminary proxy statements - Aug. 11, 2016

Securities to be offered to employees in employee benefit plans - Aug. 5, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - Aug. 5, 2016

Biocept Reports 2016 Second Quarter Financial Results - Aug. 2, 2016

CFO of Biocept just picked up 75,000 shares - Aug. 1, 2016

Departure of Directors or Certain - Aug. 1, 2016

CFO of Biocept just declared ownership of no shares of Biocept - July 27, 2016

Biocept Appoints Timothy C. Kennedy As Chief Financial Officer And Senior Vice President Of Operations - July 27, 2016

Departure of Directors or Certain - July 7, 2016

Biocept's Sr VP & Sr Med Director just picked up 50,000 shares - July 7, 2016

Biocept's SR VP of R&D and CSO just picked up 50,000 shares - July 7, 2016

Biocept's CEO & President just picked up 75,000 shares - July 7, 2016

Submission of Matters to a Vote of Security - June 29, 2016

Notice of Delisting or - June 17, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - May 26, 2016

Biocept releases salary data. CEO sees compensation fall -29% - May 18, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - May 13, 2016

Biocept Reports 2016 First Quarter Financial Results - May 12, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016

Biocept Just Received a Notice of Effectiveness - May 10, 2016

Statement of acquisition of beneficial ownership by individuals - May 6, 2016

Biocept director just picked up 25,000 shares - May 5, 2016

Biocept director just picked up 50,000 shares - May 5, 2016

Biocept director just picked up 100,000 shares - May 5, 2016

Major owner of Biocept just picked up 614,273 shares - May 5, 2016

Major owner of Biocept just declared owning 14,012 shares of Biocept - May 5, 2016

Post-Effective amendments for registration statement - May 4, 2016

Post-Effective amendments for registration statement - April 29, 2016

Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants - April 29, 2016

Prospectus [Rule 424(b)(5)] - April 29, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - April 29, 2016

Biocept: Documents Incorporated By Reference TABLE OF CONTENTS Explanatory Note Part III ItemĀ 10 - April 25, 2016

Prospectus [Rule 424(b)(3)] - March 10, 2016

Annual report [Section 13 and 15(d), not S-K Item 405] - March 10, 2016

BioClinica: Biocept Reports 2015 Fourth Quarter And Full Year Financial Results - March 9, 2016

BioClinica's VP Commercial Operations was just granted 17,500 options - March 1, 2016

BioClinica's CEO & President just picked up 13,348 shares - March 1, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. GARRISON BRADFORD & ASSOCIATES INC 37,549 0.1 Sept. 30, 2016
2. BlackRock Fund Advisors 1,498 N/A Sept. 30, 2016
3. Citadel Advisors LLC 11,277 N/A Sept. 30, 2016
4. BlackRock Institutional Trust Company, N.A. 56,731 N/A Sept. 30, 2016
5. GEODE CAPITAL MANAGEMENT, LLC 27,211 N/A Sept. 30, 2016
6. ROYAL BANK OF CANADA 130 N/A Sept. 30, 2016
7. Creative Planning 5,379 N/A Sept. 30, 2016
8. MORGAN STANLEY 334 N/A Sept. 30, 2016
9. MetLife Securities, Inc 167 N/A Dec. 31, 2016
10. UBS Group AG 3,974 N/A Sept. 30, 2016
11. VANGUARD GROUP INC 143,264 N/A Sept. 30, 2016
12. Advisory Services Network, LLC 334 N/A Sept. 30, 2016

Biocept (BIOC)

140
 


Feedback